NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical Real Estate, the nation’s top privately held buyer of medical office properties throughout the U.S., has acquired the primary office building of one of Arizona’s leading ophthalmology practices. The Retinal Consultants of Arizona and Retinal Research Institute Medical Office Building in North Phoenix serves as the headquarters for Retinal Consultants of Arizona (RCA), which maintains 35 locations across Arizona. Established in 1980, RCA has g
Author: Business Wire
Children in Phoenix Receive Free Comprehensive Eye Exams and Prescription Glasses as Part of Back-to-School Public Health Event
PHOENIX–(BUSINESS WIRE)–Phoenix-area children today received free comprehensive eye exams and glasses donations as part of a back-to-school eye-health event.
Children in Phoenix Receive Free Comprehensive Eye Exams and Prescription Glasses as Part of Back-to-School Public Health Event
PHOENIX–(BUSINESS WIRE)–Phoenix-area children today received free comprehensive eye exams and glasses donations as part of a back-to-school eye-health event.
Kala Pharmaceuticals to Present at Upcoming Investor Conferences
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, today announced t…
Global Optical Coherence Tomography for Ophthalmology Market 2018-2022| Conventional OCT Systems Dominates the Global Market| Technavio
LONDON–(BUSINESS WIRE)–#MedicalImaging–Technavio market research analysts expect the global optical coherence tomography for ophthalmology market to grow at a CAGR of almost 7% until 2022.
Ocular Therapeutix™ to Present at the H.C. Wainwright 20th Annual Global Investment Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Anto…
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug Designation From U.S. FDA For the Treatment of Bietti’s Crystalline Dystrophy (BCD)
HONG KONG & NEW YORK–(BUSINESS WIRE)–Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio’s RBIO-101 program (AAV.CYP4V2), an AAV-based gene therapy product for treating Bietti’s Crystalline Dystrophy (BCD). “Receiving orphan drug designation from the FDA is a miles
European Commission Designates OMS721 as an Orphan Medicinal Product for Treatment in Hematopoietic Stem Cell Transplantation
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that the European Commission (EC) has adopted a decision designating OMS721 as an Orphan Medicinal Product in the European Union (EU) for treatment in hematopoietic stem cell transplantation (HSCT). The adoption by the EC follows a positive opinion for orphan designation of OMS721 in this indication by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP). OMS721 is Omeros’ lead human mono
Global Ophthalmic Drugs Market 2018-2023: Analysis by Drugs and Geography – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Drugs Market – Segmented by Drugs and Geography – Growth, Trends, and Forecast (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic drugs market is expected to …
$3 Billion Retinal Surgery Devices Market – Global Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Global Forecast to 2025” company profile has been added to ResearchAndMarkets.com’s offering. The global retinal sur…
Children in Houston Receive Free Vision Screenings, Eye Exams and Prescription Glasses as Part of Back-to-School Public Health Event
HOUSTON–(BUSINESS WIRE)–Children and families received free vision screenings and prescription glasses as part of a back-to-school public health event in Houston.
EyeSouth Expands into South Florida Through Affiliation with Florida Eye Microsurgical Institute
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with Florida Eye Microsurgical Institute and Boynton Beach ASC (“Florida Eye Microsurgical”), expanding its presence into the South Florida region. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity firm. Florida Eye Microsurgical is led by ophthalmolog
The $3.91Bn Global Market for Eye Testing Equipment to 2025: Analysis by Device, Application, End-User and Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Testing Equipment Market by Device, Application, and End User – Global Opportunity Analysis and Industry Forecast, 2017-2025” report has been added to ResearchAndMarkets.com’s offering. The global eye testing equipment…
Kala Pharmaceuticals Announces FDA Approval of INVELTYS™ for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, today announced t…
Handheld Imager Poised to Provide New Insights into Eye and Brain Diseases
WASHINGTON–(BUSINESS WIRE)–#CancerResearch–A new portable instrument will allow improved diagnosis of eye diseases and could enable early detection of brain-related diseases and trauma.
Retinal Vein Occlusion – Pipeline Insight, 2018 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Vein Occlusion – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. ‘Retinal Vein Occlusion – Pipeline Insight, 2018’ report offers comprehensive Insight of the pipeline (un…
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Second Sight to Present at Investor Conferences in September
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision …
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Penn and University of Florida scientists published proof-of-concept study results on an AAV gene therapy product candidate.
Global Contact Lens Solutions Market 2018-2022| Americas Dominates the Global Market| Technavio
LONDON–(BUSINESS WIRE)–#HealthandWellness–Technavio forecast the global contact lens solutions market to accelerate at a CAGR of around 2% during 2018-2022.